(Q40591036)

21 September 2017

Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

1 reference

Streptococcus pneumoniae

1 reference

0 references

J. Verhaegen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

S. J. Vandecasteele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

J. Vandeven

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

N. Verbiest

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

K. Lagrou

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

W. E. Peetermans

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12723258

29 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12723258

29 December 2023

publication date

1 January 2003

1 reference

full work available at URL

21 September 2017

http://www.tandfonline.com/doi/pdf/10.1179/acb.2003.58.1.003

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

29 December 2023

1 reference

21 September 2017

58

1 reference

21 September 2017

1

1 reference

21 September 2017

19-26

1 reference

Acute bacterial meningitis in adults. A review of 493 episodes

21 September 2017

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Bacterial meningitis in the United States in 1995. Active Surveillance Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Streptococcus pneumoniae causes experimental meningitis following intranasal and otitis media infections via a nonhematogenous route

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Failure of cefotaxime and meropenem to eradicate meningitis caused by an intermediately susceptible Streptococcus pneumoniae strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Antibacterial agents in infections of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Antibiotic pharmacodynamics in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Gemifloxacin is effective in experimental pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Single- and multi-step resistance selection study of gemifloxacin compared with trovafloxacin, ciprofloxacin, gatifloxacin and moxifloxacin in Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FACB.2003.58.1.003

Management of infections due to antibiotic-resistant Streptococcus pneumoniae

21 January 2018

7

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

Antibiotic Susceptibility and Serotype Distribution ofStreptococcus pneumoniaeCausing Meningitis in Italy, 1997–1999

29 December 2023

11

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Belgium-update (1994-98)

29 December 2023

12

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits

29 December 2023

19

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

Pharmacodynamics of gatifloxacin in cerebrospinal fluid in experimental cephalosporin-resistant pneumococcal meningitis

29 December 2023

20

1 reference

https://api.crossref.org/works/10.1179/ACB.2003.58.1.003

29 December 2023

Identifiers

1 reference

21 September 2017

1 reference